Concepedia

Kevin Dinnell

KD

Statistics

Publications

6

Citations

205

H-Index

6

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Kevin Dinnell is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and immunology.

Top concepts

Publications per year

1999–2006

6

Publications

6

2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution

Laura C. Cooper, Gary G. Chicchi, Kevin Dinnell et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 70 citations · Full text

, , +5

2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent

Kevin Dinnell, Gary G. Chicchi, Madhumeeta J Dhar et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 56 citations · Full text

, , +7

3,4-Fused cyclohexyl sulfones as γ-secretase inhibitors

Duncan Shaw, Jonathan D. Best, Kevin Dinnell et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 31 citations · Full text

, , +9

A convenient method for the preparation of aryl cyclopropyl ethers from phenols

Gregory J. Hollingworth, Kevin Dinnell, Laura C. Dickinson et al. · Tetrahedron Letters · 1999 · 20 citations

, , +6

4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II

Laura C. Cooper, Emma Carlson, José L. Castro et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 18 citations · Full text

, , +4

1–5 of 6